Targeting undruggable carbohydrate recognition sites through focused fragment library design.


Journal

Communications chemistry
ISSN: 2399-3669
Titre abrégé: Commun Chem
Pays: England
ID NLM: 101725670

Informations de publication

Date de publication:
20 May 2022
Historique:
received: 05 01 2022
accepted: 29 04 2022
entrez: 25 1 2023
pubmed: 26 1 2023
medline: 26 1 2023
Statut: epublish

Résumé

Carbohydrate-protein interactions are key for cell-cell and host-pathogen recognition and thus, emerged as viable therapeutic targets. However, their hydrophilic nature poses major limitations to the conventional development of drug-like inhibitors. To address this shortcoming, four fragment libraries were screened to identify metal-binding pharmacophores (MBPs) as novel scaffolds for inhibition of Ca

Identifiants

pubmed: 36697615
doi: 10.1038/s42004-022-00679-3
pii: 10.1038/s42004-022-00679-3
pmc: PMC9814205
doi:

Types de publication

Journal Article

Langues

eng

Pagination

64

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : RA1944/7-1
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-17-CE11-0048
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-17-EURE-0003

Informations de copyright

© 2022. The Author(s).

Références

Oncotarget. 2016 Jun 7;7(23):35478-89
pubmed: 27007155
ACS Chem Biol. 2016 Sep 16;11(9):2407-13
pubmed: 27458873
Nat Rev Immunol. 2009 Jul;9(7):465-79
pubmed: 19521399
J Med Chem. 2019 Oct 24;62(20):9201-9216
pubmed: 31553873
Cell. 2000 Mar 3;100(5):587-97
pubmed: 10721995
ACS Chem Biol. 2018 Jan 19;13(1):36-44
pubmed: 29202222
Angew Chem Int Ed Engl. 2022 Jan 3;61(1):e202109339
pubmed: 34713573
J Biol Chem. 2012 Feb 3;287(6):4335-47
pubmed: 22170069
FEMS Microbiol Rev. 2014 Jul;38(4):598-632
pubmed: 24188132
Nature. 2021 Oct;598(7880):342-347
pubmed: 34464958
J Virol. 2004 Jun;78(11):5642-50
pubmed: 15140961
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Angew Chem Int Ed Engl. 2021 Apr 6;60(15):8104-8114
pubmed: 33314528
Nucleic Acid Ther. 2018 Jun;28(3):109-118
pubmed: 29792572
Nat Rev Drug Discov. 2021 Mar;20(3):217-243
pubmed: 33462432
Curr Opin Struct Biol. 2017 Jun;44:190-200
pubmed: 28544984
J Am Chem Soc. 2016 Sep 21;138(37):12176-86
pubmed: 27560542
ACS Chem Biol. 2018 Dec 21;13(12):3229-3235
pubmed: 30480432
Org Biomol Chem. 2016 Aug 16;14(33):7933-48
pubmed: 27488655
Curr Opin Chem Biol. 2019 Dec;53:51-67
pubmed: 31470348
Cell. 2000 Mar 3;100(5):575-85
pubmed: 10721994
Trends Immunol. 2002 Oct;23(10):480-5
pubmed: 12297419
ACS Chem Biol. 2013 Sep 20;8(9):1925-30
pubmed: 23869965
Microbes Infect. 2004 Feb;6(2):221-8
pubmed: 15049333
Front Immunol. 2014 Jul 10;5:323
pubmed: 25071783
ChemistryOpen. 2015 Oct 13;4(6):756-67
pubmed: 27308201
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:1-16
pubmed: 23962882
J Exp Med. 2003 Jan 6;197(1):7-17
pubmed: 12515809
FEBS Lett. 2006 Feb 6;580(3):982-7
pubmed: 16438968
Sci Transl Med. 2014 Apr 16;6(232):232ra51
pubmed: 24739759
Org Biomol Chem. 2013 Sep 25;11(40):6906-18
pubmed: 24057051
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
pubmed: 12824418
Chemistry. 2019 Mar 21;25(17):4478-4490
pubmed: 30690814
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Immunol Rev. 2010 Mar;234(1):120-41
pubmed: 20193016
J Biomed Biotechnol. 2012;2012:732191
pubmed: 22665991
Autoimmunity. 2006 Dec;39(8):691-704
pubmed: 17178566
Protein Eng Des Sel. 2011 Sep;24(9):659-69
pubmed: 21540232
Nat Biotechnol. 2007 Jan;25(1):84-90
pubmed: 17211407
J Am Chem Soc. 2018 Feb 21;140(7):2537-2545
pubmed: 29272578
Nat Immunol. 2008 Jun;9(6):593-601
pubmed: 18490910
Ann Glob Health. 2015 Sep-Oct;81(5):645-53
pubmed: 27036721
Appl Biochem Biotechnol. 2012 Oct;168(3):629-37
pubmed: 22826026
Adv Exp Med Biol. 2013;762:45-70
pubmed: 22975871
Nat Rev Drug Discov. 2002 Sep;1(9):727-30
pubmed: 12209152
Chem Rev. 2015 Jan 14;115(1):525-61
pubmed: 25495138
Glycobiology. 2021 Feb 9;31(2):159-165
pubmed: 32573695
Immunol Cell Biol. 2010 May-Jun;88(4):351-60
pubmed: 20351747
J Chem Inf Comput Sci. 2001 May-Jun;41(3):856-64
pubmed: 11410068
Nat Rev Drug Discov. 2009 Aug;8(8):661-77
pubmed: 19629075
Eur J Med Chem. 2021 Oct 15;222:113561
pubmed: 34146913
Drug Discov Today. 2004 May 15;9(10):430-1
pubmed: 15109945
J Am Chem Soc. 2013 Feb 20;135(7):2518-29
pubmed: 23360500
Angew Chem Int Ed Engl. 2020 Dec 21;59(52):23763-23771
pubmed: 32915505
Angew Chem Int Ed Engl. 2020 Feb 3;59(6):2204-2210
pubmed: 31724281
J Am Chem Soc. 2018 Nov 7;140(44):14915-14925
pubmed: 30303367
Nat Rev Cancer. 2005 Jul;5(7):526-42
pubmed: 16069816
Nat Rev Microbiol. 2018 Jul;16(7):440-452
pubmed: 29674747
Chem Rev. 2019 Jan 23;119(2):1323-1455
pubmed: 30192523
Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7292-7296
pubmed: 28523851
J Virol. 2002 Jul;76(13):6841-4
pubmed: 12050398

Auteurs

Elena Shanina (E)

Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Mühlenberg 1, 14424, Potsdam, Germany.
Freie Universität Berlin, Department of Chemistry and Biochemistry, Arnimallee 22, 14195, Berlin, Germany.

Sakonwan Kuhaudomlarp (S)

University Grenoble Alpes, CNRS, CERMAV, Grenoble, France.
Department of Biochemistry, Faculty of Science, Mahidol University, 10400, Bangkok, Thailand.
Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, 10400, Bangkok, Thailand.

Eike Siebs (E)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Saarland University, Department of Chemistry, 66123, Saarbrücken, Germany.
German Center for Infection Research (DZIF), Hannover-Braunschweig, Germany.

Felix F Fuchsberger (FF)

Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Mühlenberg 1, 14424, Potsdam, Germany.
Freie Universität Berlin, Department of Chemistry and Biochemistry, Arnimallee 22, 14195, Berlin, Germany.
University of Vienna, Department of Pharmaceutical Sciences, Althanstrasse 14, 1090, Vienna, Austria.
University of Vienna, Department of Microbiology, Immunology and Genetics, Max F. Berutz Labs, Biocenter 5, 1030, Vienna, Austria.

Maxime Denis (M)

University of Vienna, Department of Pharmaceutical Sciences, Althanstrasse 14, 1090, Vienna, Austria.
University of Vienna, Department of Microbiology, Immunology and Genetics, Max F. Berutz Labs, Biocenter 5, 1030, Vienna, Austria.

Priscila da Silva Figueiredo Celestino Gomes (P)

Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France.
Department of Physics, College of Sciences and Mathematics, Auburn University, 36849, Auburn, AL, USA.

Mads H Clausen (MH)

Technical University of Denmark, Center for Nanomedicine and Theranostics, Department of Chemistry, Kemitorvet 207, 2800, Kongens Lyngby, Denmark.

Peter H Seeberger (PH)

Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Mühlenberg 1, 14424, Potsdam, Germany.
Freie Universität Berlin, Department of Chemistry and Biochemistry, Arnimallee 22, 14195, Berlin, Germany.

Didier Rognan (D)

Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France.

Alexander Titz (A)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Saarland University, Department of Chemistry, 66123, Saarbrücken, Germany.
German Center for Infection Research (DZIF), Hannover-Braunschweig, Germany.

Anne Imberty (A)

University Grenoble Alpes, CNRS, CERMAV, Grenoble, France.

Christoph Rademacher (C)

Max Planck Institute of Colloids and Interfaces, Department of Biomolecular Systems, Am Mühlenberg 1, 14424, Potsdam, Germany. christoph.rademacher@univie.ac.at.
Freie Universität Berlin, Department of Chemistry and Biochemistry, Arnimallee 22, 14195, Berlin, Germany. christoph.rademacher@univie.ac.at.
University of Vienna, Department of Pharmaceutical Sciences, Althanstrasse 14, 1090, Vienna, Austria. christoph.rademacher@univie.ac.at.
University of Vienna, Department of Microbiology, Immunology and Genetics, Max F. Berutz Labs, Biocenter 5, 1030, Vienna, Austria. christoph.rademacher@univie.ac.at.

Classifications MeSH